HomeSLXN • NASDAQ
add
Silexion Therapeutics Corp
Previous close
$1.94
Day range
$1.80 - $2.05
Year range
$1.80 - $41.85
Market cap
3.11M USD
Avg Volume
746.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
FXStreet
9 hours ago
Dow Jones and Nasdaq 100 on the edge: Key support levels tested as pullback
looms
1.57%
1.63%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | -8.04M | -999.32% |
Net income | 11.85M | 1,405.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 8.06M | 987.45% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.97M | — |
Total assets | 3.09M | — |
Total liabilities | 7.67M | — |
Total equity | -4.58M | — |
Shares outstanding | 1.24M | — |
Price to book | -0.53 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 11.85M | 1,405.84% |
Cash from operations | -2.65M | -287.30% |
Cash from investing | -16.00K | -122.22% |
Cash from financing | 2.92M | — |
Net change in cash | 276.00K | 140.65% |
Free cash flow | — | — |
About
Founded
2008
Website
